https://www.biospace.com/employer/3042439/cytiva Cytiva en-US Wed, 08 Apr 2020 08:16:04 GMT https://www.biospace.com/avacta-and-cytiva-collaborating-on-covid-19-rapid-test Partnership to develop and manufacture a rapid test for the COVID-19 coronavirus infection for population screening Wed, 08 Apr 2020 08:16:04 GMT https://www.biospace.com/avacta-and-cytiva-collaborating-on-covid-19-rapid-test https://www.biospace.com/avacta-successfully-generates-several-highly-specific-affimer-reagents-for-covid-19-antigen-rapid-test-ahead-of-schedule-as-part-of-cytiva-partnership Avacta Group plc, the developer of Affimer® biotherapeutics and reagents, is pleased to announce that, in only four weeks and well ahead of schedule, it has successfully generated multiple Affimer reagents that bind the SARS-COV-2 viral antigen as part of its collaboration with Cytiva to develop an Affimer-based rapid test for the COVID-19 coronavirus infection. Wed, 22 Apr 2020 08:06:05 GMT https://www.biospace.com/avacta-successfully-generates-several-highly-specific-affimer-reagents-for-covid-19-antigen-rapid-test-ahead-of-schedule-as-part-of-cytiva-partnership https://www.biospace.com/danaher-completes-sale-of-certain-businesses-to-sartorius-ag-to-satisfy-regulatory-requirement-for-cytiva-acquisition Danaher Corporation (NYSE: DHR) ("Danaher") announced today it completed the sale of its label-free biomolecular characterization, chromatography hardware and resins, microcarriers and particle validation standards, single use tangential flow filtration systems, and stainless steel hollow fiber tangential flow filtration systems busines Thu, 30 Apr 2020 13:06:11 GMT https://www.biospace.com/danaher-completes-sale-of-certain-businesses-to-sartorius-ag-to-satisfy-regulatory-requirement-for-cytiva-acquisition https://www.biospace.com/avacta-ships-sars-cov-2-affimer-reagents-to-cytiva-and-adeptrix Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that today it is shipping Affimer reagents for COVID-19 antigen testing to its diagnostic test development partners. Mon, 11 May 2020 16:46:04 GMT https://www.biospace.com/avacta-ships-sars-cov-2-affimer-reagents-to-cytiva-and-adeptrix https://www.biospace.com/danaher-to-webcast-bioprocessing-investor-and-analyst-meeting-at-cytiva Danaher Corporation will host a live video webcast of its Bioprocessing Investor and Analyst Meeting at Cytiva on September 15, 2022 beginning at approximately 12:00 p.m. ET. Thu, 01 Sep 2022 21:06:05 GMT https://www.biospace.com/danaher-to-webcast-bioprocessing-investor-and-analyst-meeting-at-cytiva https://www.biospace.com/cytiva-strengthens-cell-line-development-with-cevec-acquisition Global life sciences leader Cytiva has acquired CEVEC Pharmaceuticals, a leading German provider of high-performance cell line development and viral vector manufacturing technologies. Thu, 06 Oct 2022 06:06:06 GMT https://www.biospace.com/cytiva-strengthens-cell-line-development-with-cevec-acquisition https://www.biospace.com/acurabio-expands-cgmp-plasmid-dna-cdmo-services-with-cytiva-s-latest-single-use-purification-technology-to-alleviate-supply-constraints-for-mrna-and-cell-and-amp-gene-therapies AcuraBio, a leading Australian biopharmaceutical contract development and manufacturing organization (CDMO), will provide a cGMP plasmid DNA CDMO service to the world using Cytiva's new process platform technology. Fri, 10 Feb 2023 15:36:06 GMT https://www.biospace.com/acurabio-expands-cgmp-plasmid-dna-cdmo-services-with-cytiva-s-latest-single-use-purification-technology-to-alleviate-supply-constraints-for-mrna-and-cell-and-amp-gene-therapies https://www.biospace.com/multiply-labs-collaborates-with-industry-leaders-university-of-california-san-francisco-cytiva-thermo-fisher-scientific-and-charles-river-to-deliver-a-successful-proof-of-concept-of-robotic-cell-therapy-manufacturing Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs, announced that its proof-of-concept robotic system, developed along with UCSF, Cytiva, Thermo Fisher Scientific and Charles River, has been successfully completed. Wed, 11 Oct 2023 13:16:10 GMT https://www.biospace.com/multiply-labs-collaborates-with-industry-leaders-university-of-california-san-francisco-cytiva-thermo-fisher-scientific-and-charles-river-to-deliver-a-successful-proof-of-concept-of-robotic-cell-therapy-manufacturing https://www.biospace.com/toronto-centre-solving-cell-manufacturing-challenges-to-benefit-patients-and-global-industry-ccrm-and-cytiva-formerly-part-of-ge-healthcare-life-sciences-renew-collaboration-agreement-for-centre-for-advanced-therapeutic-cell-technologies With Health Canada and the Food and Drug Administration beginning to approve and reimburse cell and gene therapies in significant numbers, the demand for cell and viral vector manufacturing will continue to grow. Tue, 02 Jun 2020 10:06:04 GMT https://www.biospace.com/toronto-centre-solving-cell-manufacturing-challenges-to-benefit-patients-and-global-industry-ccrm-and-cytiva-formerly-part-of-ge-healthcare-life-sciences-renew-collaboration-agreement-for-centre-for-advanced-therapeutic-cell-technologies https://www.biospace.com/avacta-provides-update-on-covid-19-rapid-antigen-test-development-partnership-with-cytiva Positive initial data from first Affimer-based rapid test strips for SARS-COV-2 spike protein Wed, 24 Jun 2020 07:56:03 GMT https://www.biospace.com/avacta-provides-update-on-covid-19-rapid-antigen-test-development-partnership-with-cytiva